A Review of the Impact of the COVID-19 Pandemic on Colorectal Cancer Screening: Implications and Solutions

被引：17

作者：

Sundaram, Suneha ^{[1
]}

Olson, Sean ^{[2
]}

Sharma, Paranjay ^{[3
]}

Rajendra, Shanmugarajah ^{[4
,5
,6
]}

机构：

[1] Robert Wood Johnson Univ Hosp, Dept Med, Rahway, NJ 07065 USA

[2] Kansas City Univ, Kansas City, MO 64106 USA

[3] Barstow Sch, Kansas City, MO 64114 USA

[4] Univ New South Wales, South Western Sydney Clin Sch, Sydney, NSW 2052, Australia

[5] Ingham Inst Appl Med, Gastrointestinal Viral Oncol Grp, Sydney, NSW 2170, Australia

[6] South Western Sydney Local Hlth Network, Bankstown Lidcombe Hosp, Dept Gastroenterol & Hepatol, Sydney, NSW 2200, Australia

来源：

PATHOGENS | 2021年 / 10卷 / 11期

关键词：

COVID-19; SARS-CoV-2; colorectal cancer; screening; colonoscopy; fecal immunochemical test; ENGLAND;

D O I：

10.3390/pathogens10111508

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The COVID-19 pandemic has impacted all aspects of medical care, including cancer screening and preventative measures. Colorectal cancer screening declined significantly at the onset of the pandemic as the result of an intentional effort to conserve resources, prioritize emergencies and reduce risk of transmission. There has already been an increase in diagnosis at more advanced stages and symptomatic emergencies due to suspended screenings. As endoscopy units find their way back to pre-pandemic practices, a backlog of cases remains. The missed CRC diagnoses amongst the missed screenings carry a risk of increased morbidity and mortality which will only increase as time-to-diagnosis grows. This review discusses the impact of COVID-19 on colonoscopy screening rates, trends in stages/symptoms/circumstances at diagnosis, and economic and social impact of delayed diagnosis. Triaging and use of FITs are proposed solutions to the challenge of catching up with the large number of pandemic-driven missed CRC screenings.

引用

页数：9

共 33 条

[1]

AASLD ACG AGA ASGE Joint GI Society, 2020, MESS COVID 19 COVID

[2] Impact of COVID-19 on colorectal cancer presentation [J].